Delivery Order SPE2DB20D3303-SPE2DB24FA0NV

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The order is for Metoprolol Succinate Extended Release 25 mg tablets, a cardiovascular medication, with a ceiling value of $1,568.34. The contract has a period of performance through September 9, 2024 and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.36 firm fixed-price delivery order is for the supply of 1,000 units of Metoprolol Succinate Extended-Release 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the medication Metoprolol Succinate Extended-Release 100 mg tablets. The contract has a firm fixed price of $5,030.32 and a completion date of May 23, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,237.68 firm fixed price delivery order is for the supply of 4,566,307,621 tablets of the cardiovascular medication Metoprolol Succinate Extended Release 100 mg. The contract has a completion date of November 4, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,558,059,646 units of the drug Metoprolol Succinate Extended-Release 25 mg tablets. The contract has a firm fixed price of $4,088.37 and an ultimate completion date of August 11, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This is a Delivery Order for $2,363.75 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,665,154 units of the medication Metoprolol Succinate Extended Release 50mg Tablets, which are critical medical commodities used to support military treatment programs and federal healthcare providers. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,507.33, is for the delivery of Metoprolol Succinate Extended-Release 100 mg tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of September 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.56 firm fixed-price delivery order is for the supply of 4,566,209,977 units of Metoprolol Succinate Extended-Release 50mg Tablets. The contract has an ultimate completion date of October 28, 2024. This award is not designated as a set-aside contract. The contract is associated with a larger Indefinite...
This federal contract award is for the delivery of Metoprolol Succinate Extended-Release 25mg tablets in 1,000-count bottles to the Defense Logistics Agency (DLA). The $6,335.98 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 23, 2022 with a completion date of September 26, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0NV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Metoprolol Succinate Extended-Release Tablets, 25 milligrams. The contract has a ceiling value of $1,192.20 and a period of performance through July 1, 2024. The award is not designated as a set-aside contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 5/17/25, 10:12 AM